home / stock / mdbif / mdbif news
iBio (IBIO +14.7%) says that its next-generation COVID-19 vaccine candidate, IBIO-202, may be effective against the Omicron variant. "Omicron’s mutations do not occur in the region selected for our IBIO-202 [nucleocapsid] protein subunit vaccine candidate, as was the case wit...
Medibio Granted CE Mark Approval for MEBsleep PR Newswire MINNEAPOLIS , Jan. 19, 2021 /PRNewswire/ -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging ...
News, Short Squeeze, Breakout and More Instantly...
Medibio Ltd Company Name:
MDBIF Stock Symbol:
OTCMKTS Market:
Medibio Granted CE Mark Approval for MEBsleep PR Newswire MINNEAPOLIS , Jan. 19, 2021 /PRNewswire/ -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging ...